Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes

References

• Bu J, Feng Q, Ran J, et al. Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetes and normoglycemic subjects. Diabetes Res Clin Pract 2012;96:163-9
   PubMed Web of Science ®Google Scholar
• Faria G, Goncalves A, Cunha R, et al. Beyond central adiposity: liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients. Int J Surg 2015;14:75-9
   PubMed Web of Science ®Google Scholar
• Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010;33:920-2
   PubMed Web of Science ®Google Scholar
• Bays HE, Gonzalez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6:343-68
   PubMedGoogle Scholar
• Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity 2010;18:2191-8
   PubMed Web of Science ®Google Scholar
• Oka R, Yagi K, Sakurai M, et al. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb 2012;19:814-22
   PubMed Web of Science ®Google Scholar
• Frederiksen L, Nielsen TL, Wraae K, et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009;94:4010-15
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Thaete FL, Simoneau JA, et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-85
   PubMed Web of Science ®Google Scholar
• Premanath M, Basavanagowdappa H, Mahesh M, et al. Occurrence of diabetes mellitus in obese nondiabetic patients, with correlative analysis of visceral fat, fasting insulin, and insulin resistance: a 3-year follow-up study (Mysore Visceral Adiposity in Diabetes Follow-up Study). India J Endocrinol Metab 2017,21:308-15
   PubMedGoogle Scholar
• Jorge-Galarza E, Medina-Urrutia A, Posadas-Sánchez R, et al. Adipose tissue dysfunction increases fatty liver association with prediabetes and newly diagnosed type 2 diabetes mellitus. Diabetol Metab Syndr 2016,8:73
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, Jenkinson CP, Richardson DK, et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006;55:1430-5
   PubMed Web of Science ®Google Scholar
• Faerch K, Vaag A, Holst JJ, et al. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 2009;32:439-44
   PubMed Web of Science ®Google Scholar
• Kopelman PG. Obesity as a medical problem (Review). Nature 2000;404:635-43
   PubMed Web of Science ®Google Scholar
• Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 2003;26:650-5
   PubMed Web of Science ®Google Scholar
• Indulekha V, Anjana RM, Surendar J, et al. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 2011;44:281-7
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015;38:S1-S93
   PubMed Web of Science ®Google Scholar
• Xing XY, Yang WY, Yang ZJ. The diagnostic significance of homeostasis model assessment of insulin resistance in Metabolic Syndrome among subjects with different glucose tolerance (Chinese). Chin J Diabetes 2004;12:182-6
   Google Scholar
• Metabolic Syndrome Research Cooperation Group of Chinese Medical Association Diabetes Branch. Recommendation of metabolic syndrome by Chinese Diabetes Society. Chin J Diabetes 2004;12:156-61
   Google Scholar
• Jia WP, Lu JX, Xiang KS, et al. Prediction of abdominal visceral obesity from body mass index, waist circumference, and waist-hip ratio in Chinese adults: receiver operating characteristic curve analysis. Biomed Environ Sci 2003;16:206-11
   PubMed Web of Science ®Google Scholar
• Stefan N, Fritsche A, Schick F, et al. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016;4:789-98
   PubMed Web of Science ®Google Scholar
• Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-50
   PubMed Web of Science ®Google Scholar
• Hayashi T, Boyko EJ, McNeely MJ, et al. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008;57:1269-75
   PubMed Web of Science ®Google Scholar
• Pourhassan M, Gluer CC, Pick P, et al. Impact of weight loss-associated changes in detailed body composition as assessed by whole-body MRI on plasma insulin levels and homeostatis model assessment index. Eur J Clin Nutr 2017;71:212-18
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Glass L, Triplitt C, et al. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002;283:E1135-43
   PubMed Web of Science ®Google Scholar
• Stefan N, Haring HU, Hu FB, et al. Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications. Lancet Diabetes Endocrinol 2016;4:457-67
   PubMed Web of Science ®Google Scholar
• Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-16
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430-5
   PubMed Web of Science ®Google Scholar
• Shin SW, Lee SJ. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014;371:2236
   PubMed Web of Science ®Google Scholar
• Viljanen AP, Lautamaki R, Jarvisalo M, et al. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin- mediated glucose uptake in healthy obese subjects. Ann Med 2009;41:152-60
   PubMed Web of Science ®Google Scholar
• Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007;87:507-20
   PubMed Web of Science ®Google Scholar
• Tordjman J, Poitou C, Hugol D, et al. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. Hepatology 2009;51:354-62
   Web of Science ®Google Scholar
• Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-81
   PubMed Web of Science ®Google Scholar
• Ascaso JF, Romero P, Real JT, et al. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med 2003;14:101-6
   Google Scholar
• Ohnishi H, Saitoh S, Takagi S, et al. Incidence of insulin resistance in obese subjects in a rural Japanese population: the Tanno and Sobetsu study. Diabetes Obes Metab 2005;7:83-7
   PubMed Web of Science ®Google Scholar
• Lemieux S, Prud’homme D, Bouchard C, et al. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993;58:463-7
   PubMed Web of Science ®Google Scholar
• Cartier A, Cote M, Lemieux I, et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr 2009;89:1307-14
   PubMed Web of Science ®Google Scholar
• Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes 2003;52:2490-6
   PubMed Web of Science ®Google Scholar
• Lemieux S, Prud’homme D, Bouchard C, et al. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993;58:463-7
   PubMed Web of Science ®Google Scholar
• Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001;4:499-502
   PubMed Web of Science ®Google Scholar
• Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-59
   PubMed Web of Science ®Google Scholar
• Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the [email protected] Study. Diabetologia 2012;55:88-93
   PubMed Web of Science ®Google Scholar
• Nordström A, Hadrévi J, Olsson T, et al. The higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab 2016;101:jc20161915
   Web of Science ®Google Scholar